Question 1

What is the catalog number for PE anti-human TCR Vα24-Jα18 (iNKT cell)?

Accepted Answer

The catalog number for PE anti-human TCR Vα24-Jα18 (iNKT cell) is GT11739.

Question 2

What sizes are available for PE anti-human TCR Vα24-Jα18 (iNKT cell)?

Accepted Answer

PE anti-human TCR Vα24-Jα18 (iNKT cell) is available in the following size(s): 100 Tests.

Question 3

Is PE anti-human TCR Vα24-Jα18 (iNKT cell) in stock?

Accepted Answer

PE anti-human TCR Vα24-Jα18 (iNKT cell) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What happens if this product doesn’t perform as expected in my experiment?

Accepted Answer

Send us the catalogue number, product name, lot number, and a summary of your results. Our technical support team will investigate and, where needed, involve the manufacturer. This is covered under our guarantee provided the product was used before its expiry date and stored correctly.

Question 5

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 6

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

PE anti-human TCR Vα24-Jα18 (iNKT cell)

Product Specifications

Reactivity

Isotype

Clone

Conjugation

Applications

Specificity

Frequently Asked Questions

Explore Other Products

CD3e (B-B12), CF740 conjugate, 0.1mg/mL

Histiocytoma Marker (D11), CF647 conjugate, 0.1mg/mL

CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3530), CF488A conjugate, 0.1mg/mL

CD81 / TAPA-1 (rC81/3442), CF405L conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2746), CF594 conjugate, 0.1mg/mL

C1QA / Complement C1q A-Chain (C1QA/2956), CF647 conjugate, 0.1mg/mL